End-of-day quote
Shanghai S.E.
06:00:00 2024-06-27 pm EDT
|
5-day change
|
1st Jan Change
|
20.84
CNY
|
-0.86%
|
|
-3.83%
|
-45.80%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
---|
Capitalization
1 |
5,461
|
3,820
|
2,998
|
Enterprise Value (EV)
1 |
3,811
|
2,810
|
2,068
|
P/E ratio
|
67.4
x
|
-700
x
|
-148
x
|
Yield
|
0.37%
|
-
|
0.34%
|
Capitalization / Revenue
|
19.8
x
|
12.6
x
|
8.18
x
|
EV / Revenue
|
13.8
x
|
9.28
x
|
5.64
x
|
EV / EBITDA
|
54
x
|
-112
x
|
-86.7
x
|
EV / FCF
|
74.2
x
|
-10.1
x
|
-21.1
x
|
FCF Yield
|
1.35%
|
-9.88%
|
-4.74%
|
Price to Book
|
3.06
x
|
2.16
x
|
1.72
x
|
Nbr of stocks (in thousands)
|
77,964
|
77,964
|
77,964
|
Reference price
2 |
70.05
|
49.00
|
38.45
|
Announcement Date
|
4/28/22
|
4/28/23
|
4/29/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
121.4
|
154.8
|
196.2
|
275.3
|
303
|
366.5
|
EBITDA
1 |
8.697
|
18.22
|
46.63
|
70.51
|
-25.19
|
-23.86
|
EBIT
1 |
1.871
|
11.38
|
40.01
|
58.17
|
-43.44
|
-47.04
|
Operating Margin
|
1.54%
|
7.35%
|
20.39%
|
21.13%
|
-14.34%
|
-12.83%
|
Earnings before Tax (EBT)
1 |
15.99
|
24.34
|
48.88
|
69.07
|
-14.71
|
-29.9
|
Net income
1 |
15.11
|
23.25
|
44.56
|
60.86
|
-5.4
|
-20.58
|
Net margin
|
12.44%
|
15.02%
|
22.71%
|
22.11%
|
-1.78%
|
-5.62%
|
EPS
2 |
0.2900
|
0.4400
|
0.7800
|
1.040
|
-0.0700
|
-0.2600
|
Free Cash Flow
1 |
-1.94
|
21.9
|
-61.44
|
51.37
|
-277.6
|
-98.04
|
FCF margin
|
-1.6%
|
14.15%
|
-31.32%
|
18.66%
|
-91.63%
|
-26.75%
|
FCF Conversion (EBITDA)
|
-
|
120.16%
|
-
|
72.85%
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
94.18%
|
-
|
84.4%
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
0.2570
|
-
|
0.1300
|
Announcement Date
|
12/18/20
|
12/18/20
|
12/8/21
|
4/28/22
|
4/28/23
|
4/29/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
73.1
|
108
|
142
|
1,650
|
1,010
|
930
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-1.94
|
21.9
|
-61.4
|
51.4
|
-278
|
-98
|
ROE (net income / shareholders' equity)
|
14.5%
|
18.8%
|
22.8%
|
5.97%
|
-0.3%
|
-1.18%
|
ROA (Net income/ Total Assets)
|
0.63%
|
3.47%
|
8.69%
|
3.13%
|
-1.35%
|
-1.45%
|
Assets
1 |
2,393
|
670.8
|
512.9
|
1,943
|
399.5
|
1,418
|
Book Value Per Share
2 |
2.150
|
2.320
|
4.360
|
22.90
|
22.70
|
22.40
|
Cash Flow per Share
2 |
1.000
|
0.3300
|
1.220
|
20.10
|
4.720
|
1.260
|
Capex
1 |
2.49
|
2.16
|
103
|
52.4
|
270
|
124
|
Capex / Sales
|
2.05%
|
1.4%
|
52.48%
|
19.02%
|
89.2%
|
33.91%
|
Announcement Date
|
12/18/20
|
12/18/20
|
12/8/21
|
4/28/22
|
4/28/23
|
4/29/24
|
|
1st Jan change
|
Capi.
|
---|
| -45.80% | 221M | | -18.02% | 8.43B | | +69.46% | 4.35B | | +7.88% | 2.78B | | -1.93% | 2.64B | | -14.28% | 1.77B | | -56.54% | 1.74B | | -16.69% | 1.48B | | +17.87% | 1.22B | | -49.60% | 1.02B |
Medical & Diagnostic Laboratories
|